Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ARVN
ARVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ARVN ETF News Today | Earnings, Events & Price Alerts
ARVN News
Arvinas, Inc. Q4 2025 Earnings Call Insights
Feb 24 2026
seekingalpha
Arvinas Reports Q4 Earnings Miss with Significant Revenue Decline
Feb 24 2026
seekingalpha
Arvinas Scheduled to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
Arvinas Appoints New CEO Randy Teel Amid 11% Stock Drop
Feb 12 2026
stocktwits
Arvinas Appoints New CEO and Board Chair
Feb 12 2026
seekingalpha
Analysis of Rapid Growth in the PROTAC Market
Feb 10 2026
Newsfilter
Arvinas Initiates ARV-393 and Glofitamab Combination Trial for DLBCL Expected in 2026
Dec 06 2025
Globenewswire
Arvinas Initiates ARV-393 and Glofitamab Combination Trial for DLBCL, Expected in 2026
Dec 06 2025
Newsfilter
Arvinas to Participate in Piper Sandler Healthcare Conference on December 4
Nov 26 2025
Globenewswire
Arvinas Unveils Preclinical Findings for ARV-806 Showcasing Strong and Unique Efficacy in KRAS G12D-Mutated Cancer Models at the 2025 AACR-NCI-EORTC Conference on Molecular Targets and Cancer Treatments
Oct 24 2025
Newsfilter
Patient-Reported Outcomes from the VERITAC-2 Trial Indicate Clinical Benefits of Vepdegestrant for Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer After Endocrine Therapy
Oct 20 2025
Newsfilter
Looking Ahead: 7 Analyst Predictions for Arvinas
Oct 15 2025
Benzinga
Arvinas to Showcase Findings from the Vepdegestrant Clinical Development Program at the 2025 ESMO Congress
Oct 13 2025
Newsfilter
Arvinas to Showcase Clinical Findings for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress on Parkinson's Disease and Movement Disorders®
Oct 01 2025
Newsfilter
Arvinas Plans Job Reductions, Out-Licenses Vepdegestrant, and Initiates $100 Million Stock Buyback Program
Sep 18 2025
NASDAQ.COM
Arvinas unveils $100 million stock buyback initiative
Sep 18 2025
SeekingAlpha
Show More News
